News

NANBIOSIS receives the support of the Spanish Research Agency (Ministry of Science and Innovation) financing the NANBIO-ACCESS project, in the 2022 call for Excellence Research Networks.

Today has been published the Resolution of the Presidency of the State Research Agency of the Spanish Ministry for Science and Innovation granting fund for the selected projects in the 2022 call for “RESEARCH NETWORKS” within the framework of the State Program to Promote Scientific-Technical Research and its Transfer, of the State Research Plan Scientific, Technical and Innovation

The final resolution proposal was issued on June 21, 2023, once the hearing process has been completed and prior acceptance by the interested parties.

The two years lasting project 2021-2023RED2022-134685-I “NANBIO-ACCESS” was among the selected proposals.

The main goals pursued by the projects are:

1. Promote and consolidate the offer of the NANBIOSIS strategic services, which target advanced challenges in biomedical research: our Cutting-Edge Biomedical Solutions.

2. Promote the open and competitive access to NANBIOSIS services and, especially, to our strategic services.

3. Strengthen NANBIOSIS communication tools and enhance internationalization capabilities.

The proposed activities address the coordination within NANBIOSIS and the complementarity of the capacities of its units, optimizing its resources. Actions are especially proposed to promote the participation of NANBIOSIS nodes and units to the “Cutting-Edge Biomedical Solutions” program.

• Read More

Resolution of the 2nd competitive call of 2023 for access to NANBIOSIS

NANBIOSIS is a Research Infrastructure for Biomedicine made up of the Platforms of the Center for Centro de Ivesntigación Biomedica en Red (CIBER- in the area of Bioengineering, Biomaterials, and Nanomedicine -CIBER-BBN), the Preclinical Infrastructure and the Development of Minimally Invasive Technologies, of the Jesús Usón Minimally Invasive Surgery Center (CCMIJU) and the Nanoimaging unit of the Biomedical Research Institute of Malaga-Nanomedicine Platform (IBIMA-BIONAND Platform).

NANBIOSIS as part of the Spanish Map of ICTS (an acronym for “Scientific and Technical Unique Infrastructures” in Spanish), approved by the Ministry of Science and Innovation, is open to all interested national and international users who may come either from the public or the private sector, and who can apply for access under the “Competitive Open Access” or “Access on Demand” modalities.

The 20% of the NANBIOSIS Units’ capacity is granted on the Competitive Open Access modality and will be prioritized according to scientific and technical quality and singularity of the applictions.

Consult the Resolution and details here

Jesús Santamaría, Scientific Director of NANBIOSIS Unit 9, elected foreign member of the Istituto Lombardo Accademia di Science et Lettere

Jesús Santamaría, Professor of Chemical Engineering at the University of Zaragoza, has been elected a foreign member of the Istituto Lombardo Accademia di Science et Lettere, in its division of Mathematical and Natural Sciences, Chemistry section.

This institution was originally founded by Napoleon Bonaparte in 1797, as the National Institute of the Cisalpine Republic, in charge of collecting discoveries and perfecting the arts and sciences, following the model of the Institut de France. Napoleon himself appointed the first members of the Institute and its first president, Alesssandro Volta, Italian chemist and physicist, famous primarily for the discovery of methane in 1776 and the invention and development of the electric battery in 1799 .

Today the Istituto Lombardo depends on the Italian Ministry of Culture with headquarters in the Brera Palace, and has maintained its founding task of contributing to “issues related to education and public welfare. It currently develops a wide program of activities, including support for research in the fields of action of the institution, numerous events and public conferences, as well as its publications and the management of its famous archives and library.

Among the members who have belonged to the Istituto Lombardo are, in addition to Napoleon himself and Volta, the poet Vincenzo Monti, the writer and politician Alessandro Manzoni, the philosopher Carlo Cattaneo and the cleric Achille Ratti, future Pope Pius XI, as well as several Nobel Prize winners. : Camillo Golgi (Medicine), Giosuè Carducci (Literature), Giulio Natta (Chemistry) and Eugenio Montale (Literature).

Professor Santamaría has a long and profuse career in the academic and scientific field, with 370 published articles, 35 doctoral theses supervised, 26 patents and participation in 18 European projects, including two of the prestigious Advanced Grants from the European Research Council (ERC),. Jesús Santamaría is the Principal Investigator of the NFP (Nanostructured Films and Particles) research group, that belongs to the Aragon Institute of Materials and Nanoscience (INMA), CSIC-UNIZAR joint center, the Aragon Health Research Institute (IIS Aragon), and the Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). He is also the Scientific Director of NANBIOSIS U9 “Synthesis of Nanoparticles Unit” since its creatrion in 2007 by UNIZAR and CIBER-BBN, recognized by the Spanish Governmen as “Unique Scientific and Technical Infraestructure” (ICTS in Spanish) .

Santamaría has been director of the Samca Chair of Nanotechnology, deputy director of the Unizar Nanoscience Institute of Aragon and editor of the Chemical Engineering Journal. He has carried out postdoctoral research stays at the University of Notre Dame and at the Massachusetts Institute of Technology (MIT), both in the United States.

His current research topics include the development of new methods for the synthesis of nanomaterials, and applications of the synthesized materials in medicine, photo-assisted catalysis, microwave catalysis, molecular recognition sensing, and nanosafety.

• Read More

New equipment adquired to improve NANBIOSIS U20

NANBIOSIS, U20. In Vivo Experimental Platform, led by Dr. Ibane Ibasolo, has been updated and improved as a result of its participation in the project FICTS1420-20, selected by the MICINN for co-financing by the FEDER Program in ICTS 2014-2020 (Equipment for setting standardized immunotoxicology assays for the U20 -NANBIOSIS I17 Action of the Investment Plan-)

A particle particle analyzer equipment (Exoid) has been inslalled at NANBIOSIS U20 for measurement of the concentration and the size of nanoparticles. The Exoid is the latest instrument from the Izon company to measure the physical characteristics of nanoparticles in electrolytic solution. Based on Tunable Resistive Pulse Sensing (TRPS) principles, the equipment is capable of measuring the size of the particles, their concentration and Z potential, through the use of a nanopore that allows measurements to be made in a defined size range.

Finally, a new upright laboratory freezer Liebherr _ SFNe 5227 has been adquired for the storage of the samples and reagents used in the different services of FVPR/U20,

• Read More

The role of microfluidics and 3D-bioprinting in the future of exosome therapy. A high impact review

Researchers of the NanoBioCel research group of the University of the Basque Country (UPV/EHU) and CIBER BBN, belonging to NANBIOSIS U10 Drug Formulation, Bioaraba, and CONICET Foundation of Argentina, have collaborated in a studio entitled: “The role of microfluidics and 3D-bioprinting in the future of the exosome therapy” which has been published in the journal Trends in Biotechnology, whose editorial seeks particularly relevant articles.

The importance of this publication lies in the novelty and potential of nanovesicles as new therapeutic agents and the versatility of microfluidic technology in combination with 3D bioprinting to bring nanovesicles closer to the clinic.

Article of reference:

Mikele Amondarain, Idoia Gallego, Gustavo Puras, Laura Saenz-del-Burgo, Carlos Luzzani, José Luis Pedraz, “The role of microfluidics and 3D-bioprinting in the future of exosome therapy”, Trends in Biotechnology,
2023, ISSN 0167-7799
https://doi.org/10.1016/j.tibtech.2023.05.006.

• Read More

Symposium Tribute to Prof. Pepe Becerra “40 years of the Bioengineering and Tissue Regeneration Laboratory (LABRET)”

Symposium on the occasion of the retirement of Prof. José Becerra Ratia: “40 years of the Bioengineering and Tissue Regeneration Laboratory (LABRET): tribute to Pepe Becerra”

We are pleased to inform about the Symposium organized by the LABRET group (Bioengineering and Tissue Regeneration Laboratory), University of Malaga, on the occasion of the retirement of Professor José Becerra.

The event will be held, only in person, on July 7 in the morning at the Faculty of Sciences of the University of Malaga

Download the program.

Prof. José Becerra was the Director of the Andalusian Center for Nanomedicine and Biotechnology (BIONAND) since February 2014, before the merger of Bionand and IBIMA (Biomedical Research Institute of Malaga) as IBIMA-Plataforma BIONAND. In fact, Prof, José Becerra took an important role in the incorporation of BIONAND into the ICTS NANBIOSIS till then integrated by Cento de Investigación Biomédica en Red (CIBER) in the area of Bioengineering, Biomaterial, and Centro de Cirugía de Mínima Invasión Jesús Usón, (CCMIJU) and he was also the first Director of the Unit 28 of NANBIOSIS.

In NANBIOSIS we want to show our gratitude to Prof. Becerra, with appreciation and admiration for his contribution to strengthening this ICTS.

Related News:

Scientists of Bionand, University of Malaga and CIBER identify a new drug that could mitigate the consequences of COVID infection.

Stem cells and COVID-19 research.

CIBER-BBN and NANBIOSIS at CIBEREDH Scientific Annual Meeting

Bionand, recently incorporated to NANBIOSIS ICTS, among the three national biotechnology reference centers.

The Medicine of the Future needs the Nanomedicine Revolution. This is why

NANBIOSIS at the Assembly of Materplat

BIONAND incorporated to the Spanish ICTS Map as a new node of NANBIOSIS

• Read More

2023 Annual Conference of CIBER-BBN and NANBIOSIS

CIBER-BBN´s Annual Conference has been scheduled for November 6-8, 2023

This year, in the framework of a CIBER program to stimulate collaborations between clinical and technological groups, the conference will be organized in cooperation with a CIBER clinical area, CIBER-EHD: Hepatic and Digestive diseases. (An internal call of collaborative projects BBN-EHD will be open by). The scheme of the event will be slightly different from previous editions:

On Monday 6 the scientific sessions will be common for EHD and BBN, with appealing contents for the mixed audience.
On Tuesday 7 EHD and BBN sessions will be specific for each area in separate rooms (with common coffee break).
The anual session dedicated to NANBIOSIS is scheduled for the afternoon of the Tuesday 7th,
After this session we will cellebrate the annual meeting of the NANBIOSIS coordination Committee and the Scientific and Technical Advisory Board of NANBIOSIS.

We will come back with further details. Book the dates!

• Read More

Representatives of the Ministry of Science and Innovation visited unit 16 of NANBIOSIS

On May 16 representatives of the General Subdirectorate of Large Scientific-Technical Facilities of the Ministry of Science and Innovation visited unit 16 of NANBIOSIS (created by Centro de Investigación Biomédica en Red -CIBER-, and the University of Extermadura).

Mrs. Beatriz Albella Rodríguez and Mrs. María Jesús Marcos Crespo, got to know first-hand the facilities of unit 16 of the CTS NANBIOSIS of “Surface Characterization and Calorimetry“ .

The visit was guided by the Scientific Director of Unit 16 of NANBIOSIS, Maria Luisa González Martín, and by Mr. Javier de Francisco Morcillo, Director of the Secretariat for Scientific Infrastructure and Technological Development Vice President for Research and Transfer of the University of Extremadura

The reason for the visit was to receive information on the use of European Regional Development Funds that have served to improve the infrastructures of the Spanish Map of Singular Scientific-Technical Infrastructures (ICTS, in Spanish) to support scientific research.

During the last years, this unit 16 of NANBIOSIS ICTS has enlarged its capacities through the project FICTS1420-14-09, an investment of 1.3 million euros, co-financed with FEDER funds, the Ministry of Science and Innovation, and Junta de Extremadura, Regional Ministry of Economy, Science and Digital Agency.

This Unit 16, located in Badajoz, offers the performance of tasks of physical-chemical characterization of surfaces using techniques such as ellipsometry, calorimetry, X-ray photoelectronic spectroscopy (XPS), and detection of secondary ions by means of mass spectrometry by time of flight (Tof-SIMS).

2nd Open call 2023 for preferential access to the NANBIOSIS ICTS

NANBIOSIS opens in June the 2nd competitive open call 2023 for its “Cutting-Edge Biomedical Solutions” and services.

The 20% of the NANBIOSIS Units’ capacity is granted on the Competitive Open Access modality and will be prioritized according to criteria of scientific and technical quality and singularity of the proposals.

There are 2 calls per year for open and competitive access that allow the prioritisation of the best service proposals. https://www.nanbiosis.es/call/

The 2nd call of 2023 will open on June 1 and applications can be submitted throughout the whole month (due date June 30^th). Access application forms submitted after that date will be processed as “access on demand” applications.

Proposals granted in the open and competitive access modality must meet, at least, one of the circumstances listed in the access application form (“order request“), in order to demmonstrate their scientifc and technical quality or singularity.

Thus, for example, applications related to R&D projects funded through national or European calls are eligible, as well as the need to carry out one of the NANBIOSIS “Cutting-Edge Biomedical Solutions” that implies the interaction of several Units, among others.

NANBIOSIS Cutting-edge Biomedical Solutions

Workshop on Hyperthermic Oncology

Next Friday, June 9, 2023, a Workshop on Oncological Hyperthermia entitled “Clinical Implementation of Oncological Hyperthermia in Spain and Europe: current situation and prospects” will be held in Barcelona. The location of the event is at the Hotel Front Marítim in Barcelona and the scheduled time is from 9:00 a.m. to 5:30 p.m.

Relevant speakers will present an updated vision on the different modalities of hyperthermia that are being used for cancer treatment. Jorge Contreras (Coordinator of the Spanish Society of Radiation Oncology ) will give a session on the current situation of clinical hyperthermia in Spain. Daniel Ortega (Coordinator of the National Network of Nanotechnology in Translational Hyperthermia) and Teresa Macarulla (Coordinating Investigator of the NoCanTher study on the use of magnetic nanoparticles associated with hyperthermia treatment in pancreatic cancer) will present their experience with a nanotechnological health product in said trial. After a break, Giammaria Fiorentini (Director of the Oncology Unit of the Muraglia di Pesaro Hospital) will give a vision of the use of electro-modulated hyperthermia in pancreatic cancer and in a round table, different professionals will give therir global vision of the application of these techniques from preclinical to clinical implementation.

In addition, regulatory aspects will also be covered. Luc van Hove (Medical, Regulatory and Clinical Affairs expert) will speak from a European perspective on the regulation of medical devices and in vitro diagnostics; while Julia Caro (Head of the area of the National Center for Certification of Sanitary Products) will do so from the perspective of a notified body.

Further information and registration at this link: https://forms.office.com/e/0251iMc2LT

There is additional information at:
-Linkedin https://www.linkedin.com/posts/safenmt_hyperthermia-magnetic-barcelona-activity-7062697943509737472-85wP?utm_source=share&utm_medium=member_desktop.
-Twitter https://twitter.com/abasolo_vhir/status/1659074218850484224

• Read More

You are here : Home / News (Page 5)

NANBIOSIS opens in June the 2nd competitive open call 2023 for its “Cutting-Edge Biomedical Solutions” and services.